A study of inter-alpha-trypsin inhibitor chains expression in liposarcomas. 2003

I Tabata, and Y Nishida, and H Sugiura, and L Zhuo, and M Yoneda, and K Kimata, and H Nakashima, and N Ishiguro
Department of Orthopaedic Surgery, Nagoya University School of Medicine, 65-Tsurum Showa, Nagoya 466 8550, Japan.

OBJECTIVE Liposarcoma is common soft tissue sarcoma that is sometimes difficult to treat, besides its good prognosis. The inter-alpha-trypsin inhibitor heavy chains (HCs) has been reported to be linked to hyaluronan, which play important roles in tumour progression and metastasis. In this study, clinical significance of HCs in patients with liposarcoma was investigated. METHODS HC expression was studied by immunohistochemistry on resected specimens of 33 liposarcoma patients and 10 lipoma patients. The expression of HC mRNA was analyzed by reverse transcription polymerase chain reaction (RT-PCR). Serum concentration of HC was determined with enzyme-linked immunosorbent assay (ELISA). RESULTS Prominent positive staining of HC was observed in extracellular matrix of pleomorphic and myxoid liposarcoma. In well-differentiated liposarcoma and lipoma, faint staining was seen with HC. No products of HC could be detected by RT-PCR. Serum concentration of HC was not up-regulated in any subtypes of liposarcoma. HC expression was not significantly correlated with tumour subtypes and prognosis. CONCLUSIONS HC was strongly accumulated in pleomorphic and myxoid liposarcoma, however, was not locally synthesized in liposarcoma. HC might play roles in stabilizing extracellular matrix, such as hyaluronan (HA), in liposarcoma.

UI MeSH Term Description Entries
D008067 Lipoma A benign tumor composed of fat cells (ADIPOCYTES). It can be surrounded by a thin layer of connective tissue (encapsulated), or diffuse without the capsule. Fatty Tumor,Hibernoma,Lipoma, Pleomorphic,Atypical Lipoma,Lipomata,Lipomatosis, Multiple,Atypical Lipomas,Fatty Tumors,Hibernomas,Lipoma, Atypical,Lipomas,Lipomas, Atypical,Lipomas, Pleomorphic,Lipomatas,Lipomatoses, Multiple,Multiple Lipomatoses,Multiple Lipomatosis,Pleomorphic Lipoma,Pleomorphic Lipomas,Tumor, Fatty,Tumors, Fatty
D008080 Liposarcoma A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed) Liposarcoma, Dedifferentiated,Liposarcoma, Pleomorphic,Atypical Lipomatous Tumor,Liposarcoma, Well Differentiated,Well Differentiated Liposarcoma,Atypical Lipomatous Tumors,Dedifferentiated Liposarcoma,Dedifferentiated Liposarcomas,Lipomatous Tumor, Atypical,Liposarcomas,Pleomorphic Liposarcoma,Pleomorphic Liposarcomas,Well Differentiated Liposarcomas
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000510 Alpha-Globulins Serum proteins that have the most rapid migration during ELECTROPHORESIS. This subgroup of globulins is divided into faster and slower alpha(1)- and alpha(2)-globulins. Alpha-Globulin,Alpha Globulin,Alpha Globulins
D012334 RNA, Neoplasm RNA present in neoplastic tissue. Neoplasm RNA
D014361 Trypsin Inhibitors Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. Trypsin Inhibitor,Inhibitor, Trypsin,Inhibitors, Trypsin
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D018208 Liposarcoma, Myxoid A liposarcoma containing round mesenchymal cells and a myxoid extracellular matrix in stroma. Myxoid Liposarcoma,Round Cell Liposarcoma,Liposarcoma, Round Cell,Liposarcomas, Myxoid,Myxoid Liposarcomas,Round Cell Liposarcomas

Related Publications

I Tabata, and Y Nishida, and H Sugiura, and L Zhuo, and M Yoneda, and K Kimata, and H Nakashima, and N Ishiguro
January 2008, Connective tissue research,
I Tabata, and Y Nishida, and H Sugiura, and L Zhuo, and M Yoneda, and K Kimata, and H Nakashima, and N Ishiguro
November 2003, Reproduction (Cambridge, England),
I Tabata, and Y Nishida, and H Sugiura, and L Zhuo, and M Yoneda, and K Kimata, and H Nakashima, and N Ishiguro
April 1989, Biological chemistry Hoppe-Seyler,
I Tabata, and Y Nishida, and H Sugiura, and L Zhuo, and M Yoneda, and K Kimata, and H Nakashima, and N Ishiguro
January 1976, Methods in enzymology,
I Tabata, and Y Nishida, and H Sugiura, and L Zhuo, and M Yoneda, and K Kimata, and H Nakashima, and N Ishiguro
April 1994, European journal of biochemistry,
I Tabata, and Y Nishida, and H Sugiura, and L Zhuo, and M Yoneda, and K Kimata, and H Nakashima, and N Ishiguro
August 1994, Biological chemistry Hoppe-Seyler,
I Tabata, and Y Nishida, and H Sugiura, and L Zhuo, and M Yoneda, and K Kimata, and H Nakashima, and N Ishiguro
December 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
I Tabata, and Y Nishida, and H Sugiura, and L Zhuo, and M Yoneda, and K Kimata, and H Nakashima, and N Ishiguro
August 1996, Journal of biochemistry,
I Tabata, and Y Nishida, and H Sugiura, and L Zhuo, and M Yoneda, and K Kimata, and H Nakashima, and N Ishiguro
January 1999, European journal of biochemistry,
I Tabata, and Y Nishida, and H Sugiura, and L Zhuo, and M Yoneda, and K Kimata, and H Nakashima, and N Ishiguro
May 1992, Electrophoresis,
Copied contents to your clipboard!